| Net loss | -814K |
| Depreciation | |
| Amortization of deferred grant income | |
| Deferred income taxes benefit | -476K |
| Share-based compensation | 93K |
| Accounts receivable | 285K |
| Materials and supplies | -297K |
| Prepaid expenses and other current assets | 475K |
| Accounts payable and accrued expenses | -153K |
| Net cash flows from operating activities | |
| Purchase of property and equipment | -2.33M |
| Proceeds from note receivable | |
| Net cash flows (used in) investing activities | |
| Borrowings under line of credit | |
| Borrowings under long term debt | 4M |
| Dividends paid | |
| Issuance of common shares for stock options exercised and employee stock purchases | 30K |
| Net cash flows from financing activities | |
| Increase (Decrease) in Cash and Cash Equivalents | 2.33M |
| Cash and Cash Equivalents, Beginning of Period | 6.28M |
| Cash and Cash Equivalents, End of Period | 8.61M |
| Cash paid during year for interest | |
| Property and equipment included in accounts payable and accrued expenses | |